Legada, Bb Boy .
HRN: 21-63-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/27/2022
08/03/2022
IV
13 Mg
Q24 Hrs
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes